Search research articles
Contact Us
Filters
Showing results (21-30 of 87) with videos related to
Page
of 9
Sort By:
Immunological Reviews
|
September 5, 2023
Type I interferon and cancer
Peter Holicek, Emma Guilbaud, Vanessa Klapp, et al.
Plos One
|
February 11, 2017
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
Nada Hradilova, Lenka Sadilkova, Ondrej Palata, et al.
Immunology Letters
|
May 13, 2017
High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy
Linda Urbanova, Nada Hradilova, Irena Moserova, et al.
Methods in Enzymology
|
February 1, 2020
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death
Lenka Kasikova, Iva Truxova, Isabelle Cremer, et al.
Immunology Letters
|
January 14, 2020
Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype
Ondrej Palata, Nada Podzimkova Hradilova, Dagmar Mysiková, et al.
Cancer Research
|
May 23, 2002
Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin
Radek Spisek, Patrice Chevallier, Nadine Morineau, et al.
Frontiers in Oncology
|
June 11, 2019
Radiotherapy in Combination With Cytokine Treatment
Ondrej Palata, Nada Hradilova Podzimkova, Eva Nedvedova, et al.
Clinical Immunology (Orlando, Fla.)
|
April 9, 2014
Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients
Jana Kayserova, Jana Vcelakova, Katerina Stechova, et al.
Methods in Enzymology
|
February 1, 2020
Methods to assess DC-dependent priming of T cell responses by dying cells
Anne-Marie Chalupova, Sarka Vosahlikova, Daniela Rozkova, et al.
Oncoimmunology
|
December 8, 2018
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 87) with videos related to
Sort By:
Page
of 9
Immunological Reviews
|
September 5, 2023
Type I interferon and cancer
Peter Holicek, Emma Guilbaud, Vanessa Klapp, et al.
Plos One
|
February 11, 2017
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
Nada Hradilova, Lenka Sadilkova, Ondrej Palata, et al.
Immunology Letters
|
May 13, 2017
High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy
Linda Urbanova, Nada Hradilova, Irena Moserova, et al.
Methods in Enzymology
|
February 1, 2020
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death
Lenka Kasikova, Iva Truxova, Isabelle Cremer, et al.
Immunology Letters
|
January 14, 2020
Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype
Ondrej Palata, Nada Podzimkova Hradilova, Dagmar Mysiková, et al.
Cancer Research
|
May 23, 2002
Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin
Radek Spisek, Patrice Chevallier, Nadine Morineau, et al.
Frontiers in Oncology
|
June 11, 2019
Radiotherapy in Combination With Cytokine Treatment
Ondrej Palata, Nada Hradilova Podzimkova, Eva Nedvedova, et al.
Clinical Immunology (Orlando, Fla.)
|
April 9, 2014
Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients
Jana Kayserova, Jana Vcelakova, Katerina Stechova, et al.
Methods in Enzymology
|
February 1, 2020
Methods to assess DC-dependent priming of T cell responses by dying cells
Anne-Marie Chalupova, Sarka Vosahlikova, Daniela Rozkova, et al.
Oncoimmunology
|
December 8, 2018
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
Page
of 9